Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence

References

• AytaçIAMcKinlayJBKraneRJThe likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequencesBJU Int199984505610444124
   PubMed Web of Science ®Google Scholar
• McKinlayJBThe worldwide prevalence and epidemiology of erectile dysfunctionInt J Impot Res200012Suppl 4S6S1111035380
   PubMed Web of Science ®Google Scholar
• GuestJFDas GuptaRHealth-related quality of life in a UK-based population of men with erectile dysfunctionPharmacoeconomics20022010911711888363
   PubMed Web of Science ®Google Scholar
• HawtonKIntegration of treatments for male erectile dysfunctionLancet1998351789433420
   PubMed Web of Science ®Google Scholar
• Fugl-MeyerARLodnertGBränholmIBFugl-MeyerKSOn life satisfaction in male erectile dysfunctionInt J Impot Res199791411489315491
   PubMed Web of Science ®Google Scholar
• MironeVFuscoFRossiASicuteriRMontorsiFTadalafil and vardenafil vs sildenafil: a review of patient-preference studiesBJU Int200910391212121719154480
   PubMed Web of Science ®Google Scholar
• FeldmanHAJohannesCBDerbyCAErectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging StudyPrev Med20003032833810731462
   PubMed Web of Science ®Google Scholar
• GuayATED2: erectile dysfunction = endothelial dysfunctionEndocrinol Metab Clin North Am20073645346317543729
   PubMed Web of Science ®Google Scholar
• NehraAErectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditionsMayo Clin Proc20098413914819181648
   PubMed Web of Science ®Google Scholar
• VlachopoulosCIoakeimidisNStefanadisCErectile dysfunction and coronary artery disease: a relationship for disclosureHellenic J Cardiol2008481618350775
   PubMed Web of Science ®Google Scholar
• KapurVChienCVFuessJESchwarzERThe relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular diseaseRev Cardiovasc Med2008918719518953278
   PubMed Web of Science ®Google Scholar
• MinerMMErectile dysfunction and the “window of curability”: a harbinger of cardiovascular eventsMayo Clin Proc20098410210419181641
   PubMed Web of Science ®Google Scholar
• ShabsighRShahMSandMErectile dysfunction and men’s health: developing a comorbidity risk calculatorJ Sex Med200851237124318439154
   PubMed Web of Science ®Google Scholar
• InmanBASt SauverJLJacobsonDJA population-based, longitudinal study of erectile dysfunction and future coronary artery diseaseMayo Clin Proc20098410811319181643
   PubMed Web of Science ®Google Scholar
• GazzarusoCSolerteSBPujiaAErectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitorsJ Am Coll Cardiol2008512040204418498958
   PubMed Web of Science ®Google Scholar
• MontorsiPRavagnaniPMGalliSAssociation between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trialEur Heart J2006272632263916854949
   PubMed Web of Science ®Google Scholar
• HodgesLDKirbyMSolankiJO’DonnellJBrodieDAThe temporal relationship between erectile dysfunction and cardiovascular diseaseInt J Clin Pract200761122019202517997808
   PubMed Web of Science ®Google Scholar
• FeldmanHAGoldsteinIHatzichristouDGKraneRJMcKinlayJBImpotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJ Urol199415154618254833
   PubMed Web of Science ®Google Scholar
• TanHMLowWYNgCJPrevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian Men: the Asian Men’s Attitudes to Life Events and Sexuality (MALES) studyJ Sex Med200741582159217908233
   PubMed Web of Science ®Google Scholar
• RosenRCFisherWAEardleyINiederbergerCNadelASandMThe multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general populationCurr Med Res Opin20042060761715171225
   PubMed Web of Science ®Google Scholar
• WespesEAmarEHatzichristouDEAU Guidelines on erectile dysfunction: an updateEur Urol20064980681516530932
   PubMed Web of Science ®Google Scholar
• MontagueDKJarowJPBroderickGAChapter 1: The management of erectile dysfunction: an AUA updateJ Urol200517423023915947645
   PubMed Web of Science ®Google Scholar
• EardleyIVardenafil: a new oral treatment for erectile dysfunctionInt J Clin Pract20045880180615372854
   PubMed Web of Science ®Google Scholar
• MontorsiFPadma-NathanHBuvatJEarliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trialJ Sex Med2004116817816422971
   PubMed Web of Science ®Google Scholar
• PorstHSharlipIDHatzichristouDExtended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled studyEur Urol20065010861094 discussion 1094–1095.16820261
   PubMed Web of Science ®Google Scholar
• MontorsiFHellstromWJValiquetteLVardenafil provides reliable efficacy over time in men with erectile dysfunctionUrology2004641187119515596195
   PubMed Web of Science ®Google Scholar
• ValiquetteLMontorsiFAuerbachSVardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction – RELY-IICan Urol Assoc J2008218719518682779
   PubMed Web of Science ®Google Scholar
• MinerMGildermanLBailenJVardenafil in men with stable statin therapy and dyslipidemiaJ Sex Med200851455146718373526
   PubMed Web of Science ®Google Scholar
• RosenbergMTAdamsPLMcBrideTARobertsJNMcCallumSWImprovement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE studyInt J Clin Pract200963273419125990
   PubMed Web of Science ®Google Scholar
• KendirciMBivalacquaTJHellstromWJVardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunctionExpert Opin Pharmacother2004592393215102574
   PubMed Web of Science ®Google Scholar
• MontorsiFSaloniaABrigantiAVardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experienceEur Urol20054761262115826752
   PubMed Web of Science ®Google Scholar
• LaumannEOPaikARosenRCSexual dysfunction in the United States: prevalence and predictorsJAMA199928153754410022110
   PubMed Web of Science ®Google Scholar
• RosenRCWingRSchneiderSGendranoNEpidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factorsUrol Clin North Am20053240341716291033
   PubMed Web of Science ®Google Scholar
• Martín-MoralesASanchez-CruzJJSaenz de TejadaIRodriguez-VelaLJiminez-CruzJFBurgos-RodriguezRPrevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina StudyJ Urol200116656957411458070
   PubMed Web of Science ®Google Scholar
• TelesAGCarreiraMAlarcãoVPrevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction studyJ Sex Med200851317132418194181
   PubMed Web of Science ®Google Scholar
• SaigalCSWessellsHPaceJSchonlauMWiltTJPredictors and prevalence of erectile dysfunction in a racially diverse populationArch Intern Med200616620721216432090
   PubMed Web of Science ®Google Scholar
• SunPSwindleRAre men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort studyJ Urol200517424424815947647
   PubMed Web of Science ®Google Scholar
• KlonerRAMullinSHShookTErectile dysfunction in the cardiac patient: how common and should we treatJ Urol2003170S46S50 discussion S50.12853773
   PubMed Web of Science ®Google Scholar
• MontorsiFBrigantiASaloniaAErectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery diseaseEur Urol200344360364 discussion 364–365.12932937
   PubMed Web of Science ®Google Scholar
• McCullochDKCampbellIWWuFCPrescottRJClarkeBFThe prevalence of diabetic impotenceDiabetologia1980182792837418954
   PubMed Web of Science ®Google Scholar
• GiulianoFALericheAJaudinotEOSolesse de GendreAPrevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or bothUrology2004641196120115596196
   PubMed Web of Science ®Google Scholar
• SasakiHYamasakiHOgawaKPrevalence and risk factors for erectile dysfunction in Japanese diabeticsDiabetes Res Clin Pract200570818916126126
   PubMed Web of Science ®Google Scholar
• PensonDFLatiniDMLubeckDPWallaceKLHenningJMLueTFDo impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) databaseDiabetes Care2003261093109912663579
   PubMed Web of Science ®Google Scholar
• ShabsighRDuvalSShahMReganTSJuhaszMVeltryLGEfficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial dataCurr Med Res Opin2007232453246017727740
   PubMed Web of Science ®Google Scholar
• SeftelADSunPSwindleRThe prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunctionJ Urol20041712341234515126817
   PubMed Web of Science ®Google Scholar
• RoumeguèreTWespesECarpentierYHoffmannPSchulmanCCErectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease riskEur Urol20034435535912932936
   PubMed Web of Science ®Google Scholar
• RaoKDuGHYangWMHyperlipidemia and erectile dysfunctionZhonghua Nan Ke Xue20061264364616894947
   PubMedGoogle Scholar
• WeiMMaceraCADavisDRHornungCANankinHRBlairSNTotal cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunctionAm J Epidemiol19941409309377977280
   PubMed Web of Science ®Google Scholar
• CoronaGFortiGMaggiMWhy can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndromeAging Male20081119319919172551
   PubMed Web of Science ®Google Scholar
• CoronaGMannucciEPetroneLA comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunctionJ Sex Med2007478979617498109
   PubMed Web of Science ®Google Scholar
• KahnRBuseJFerranniniESternMThe metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care2005282289230416123508
   PubMed Web of Science ®Google Scholar
• TraishAMGuayAFeeleyRSaadFThe dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunctionJ Androl200930102218641413
   PubMed Web of Science ®Google Scholar
• CoronaGMannucciEFortiGMaggiMHypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseasesInt J Androl2009 Epub 2009 Feb 16.
   Google Scholar
• YassinAASaadFGoorenLJMetabolic syndrome, testosterone deficiency and erectile dysfunction never come aloneAndrologia20084025926418727737
   PubMed Web of Science ®Google Scholar
• ShabsighRRajferJAversaAThe evolving role of testosterone in the treatment of erectile dysfunctionInt J Clin Pract2006601087109216939550
   PubMed Web of Science ®Google Scholar
• MorelliACoronaGFilippiSWhich patients with sexual dysfunction are suitable for testosterone replacement therapyJ Endocrinol Invest20073088088818075293
   PubMed Web of Science ®Google Scholar
• BuvatJBou JaoudeGSignificance of hypogonadism in erectile dysfunctionWorld J Urol20062465766717082935
   PubMed Web of Science ®Google Scholar
• MalavigeLSLevyJCErectile dysfunction in diabetes mellitusJ Sex Med200961232124719210706
   PubMed Web of Science ®Google Scholar
• EardleyILeeJCGuayATGlobal experiences with vardenafil in men with erectile dysfunction and underlying conditionsInt J Clin Pract2008621594160318822030
   PubMed Web of Science ®Google Scholar
• RhodenELRibeiroEPRiednerCETelokenCSoutoCAVGlycosylated haemoglobin levels and the severity of erectile function in diabetic menBJU Int20059561561715705090
   PubMed Web of Science ®Google Scholar
• GoldsteinIYoungJMFischerJBangerterKSegersonTTaylorTVardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose studyDiabetes Care20032677778312610037
   PubMed Web of Science ®Google Scholar
• IshiiNNagaoKFujikawaKTachibanaTIwamotoYKamidonoSVardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunctionInt J Urol2006131066107216903931
   PubMed Web of Science ®Google Scholar
• FieldsLEBurtVLCutlerJAHughesJRoccellaEJSorliePThe burden of adult hypertension in the United States 1999 to 2000: a rising tideHypertension20044439840415326093
   PubMed Web of Science ®Google Scholar
• van AhlenHWahleKKupperWYassinAReblinTNeureitherMSafety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensivesJ Sex Med2005285686416422810
   PubMed Web of Science ®Google Scholar
• SaltzmanEAGuayATJacobsonJImprovement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observationJ Urol200417225525815201788
   PubMed Web of Science ®Google Scholar
• EardleyILee JayCShabsighRVardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medicationsJ Sex Med2009 In press.
   Google Scholar
• PorstHYoungJMSchmidtACBuvatJEfficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroupsUrology20036251952412946758
   PubMed Web of Science ®Google Scholar
• SchnablSCorrelations and Determinants of Functional Sexual DisturbancesLittleton, MAPSG Publishing1980
   Google Scholar
• WeissPBrodySWomen’s partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplayJ Sex Med2009613514119170844
   PubMed Web of Science ®Google Scholar
• KamelAKhaouliRSabhaMAl MitwallyKFouadWLandenHThe real-life efficacy and safety of vardenafil: an international post-marketing surveillance study of 2824 patients from the Middle EastClin Drug Investig2007275339346
   PubMed Web of Science ®Google Scholar
• TobingNLArsyadKMManuputtyDLandenHSyarifHThe real-life safety and efficacy of vardenafil: an international post-marketing surveillance study from 1171 Indonesian patientsMaj Kedokt Indon2006568468473
   Google Scholar
• RajagopalanPMazzuAXiaCEffect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunctionJ Clin Pharmacol200343326026712638394
   PubMed Web of Science ®Google Scholar
• WensingGBauerRUngerSRohdeGHeinigRSimultaneous administration of vardenafil and alcohol does not result in a pharmacodynamic or pharmacokinetic interaction in healthy male subjectsInt J Clin Pharmacol Ther200644521622416724576
   PubMed Web of Science ®Google Scholar
• HellstromWJGittelmanMKarlinGVardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trialJ Androl20022376377112399521
   PubMed Web of Science ®Google Scholar
• KeatingGScottLVardenafil: a review of its use in erectile dysfunctionDrugs200363232673270314636086
   PubMed Web of Science ®Google Scholar
• RosenRCJacksonGKostisJBErectile dysfunction and cardiac disease: recommendations of the Second Princeton ConferenceCurr Urol Rep2006749049617052447
   PubMedGoogle Scholar
• KostisJBJacksonGRosenRSexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)Am J Cardiol20059685M93M
   PubMed Web of Science ®Google Scholar
• CoronaGRazzoliEFortiGMaggiMThe use of phosphodiesterase 5 inhibitors with concomitant medicationsJ Endocrinol Invest20083179980818997493
   PubMed Web of Science ®Google Scholar